TROG Cancer Research
Members Login   CQMS Login

TROG 11.03 (P_LUNG GP)


Title: A Randomised Phase III Trial of High Dose Palliative Radiotherapy (HDPRT) Versus Concurrent Chemotherapy + HDPRT (C-HDPRT) in Patients with Good Performance Status, Locally Advanced/Small Volume Metastatic Non Small Cell Lung Cancer (NSCLC) Not Suitable for Radical Chemo-Radiotherapy

Final accrual:  76

Closed to follow-up date: 31 July 2018

Trial chair: Associate Professor Margot Lehman, Princess Alexandra Hospital, QLD 

Trial contact:
Adrienne See
Clinical Trial Coordinator
Princess Alexandra Hospital, QLD
Phone: +61 7 3176 9116

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)

Clinical trial registration:
Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12612001211853

Trial documentation

Case Report Forms
Certificate of Currency

Quality Assurance

Radiation Therapy Quality Assurance Guidelines
RTQA Guidelines

QA Checklist - Post RT
QA Checklist - Chemotherapy


Become a TROG member and join our community of over 1,000 health professionals.

Latest News

  • 12 Feb 2019

    a new clinical trial by trog cancer research has shown for the first time that a new radiotherapy technique produced greater survival rates in early stage inoperable lung cancer patients, compared to conventional radiation treatment. the trog 09.02 chisel study aimed to investigate if...

  • 29 Jan 2019

    results from australia’s and new zealand’s biggest cancer trial have identified the best treatment regime for men suffering from newly-diagnosed aggressive but localised prostate cancer. the radar study, run through trog cancer research, compared the use of hormone treatment (longer v...

  • 07 Aug 2018

    trog cancer research has been successful in being awarded a $1.5 million grant (2018-2020) under the cancer australia support for cancer clinical trials program. the funding from cancer australia provides essential infrastructure for trog to build our capacity to undertake cancer...

  • 07 Aug 2018

    the board of trog cancer research is pleased to announce the appointment of susan goode as the new trog chief executive officer. susan is formerly the centre manager for the hunter cancer research alliance at the university of newcastle. in this role, she was key player in a strate...